Joel E Kamper1, Jeffrey Garofano, Daniel J Schwartz, Marc A Silva, Jamie Zeitzer, Mo Modarres, Scott D Barnett, Risa Nakase-Richardson. 1. MHBS (Drs Kamper, Silva, and Nakase-Richardson), Medicine (Dr Schwartz), and Research (Dr Barnett), James A. Haley Veterans Hospital, Tampa, Florida; Department of Psychological and Social Foundations (Mr Garofano) and Department of Medicine (Drs Schwartz and Nakase-Richardson), University of South Florida, Tampa, Florida; Department of Psychiatry and Behavioral Sciences, Stanford Center for Sleep Sciences and Medicine, Stanford University, and Mental Illness, Research, Education, and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California (Dr Zeitzer); Brain Rehabilitation Research Center, North Florida/South Georgia Veterans Health System, Gainesville, Florida (Dr Modarres); HSR&D Center of Innovation in Disability Rehabilitation and Research (Dr Nakase-Richardson), Tampa, Florida; Defense and Veterans Brain Injury Center, Silver Spring, Maryland (Drs Silva and Nakase-Richardson).
Abstract
OBJECTIVE: To examine concordance of accelerometer-based actigraphy (ACG) with polysomnography (PSG) in the determination of sleep states in inpatients with traumatic brain injury (TBI), and examine the impact of injury severity and comorbid conditions (spasticity, apnea) on concordance. PARTICIPANTS: This was a convenience sample of 50 participants with primarily severe TBI. DESIGN: This was a retrospective chart review of concurrent administration of PSG with ACG in nonconsecutive rehabilitation admissions with TBI. MAIN MEASURES: Total sleep time and sleep efficiency were measured by PSG and ACG. RESULTS: Moderate to strong correlations between ACG and PSG were observed for total sleep time (r = 0.78, P < .01) and sleep efficiency (r = 0.66, P < .01). PSG and ACG estimates of total sleep time (316 minutes vs 325 minutes, respectively) and sleep efficiency (78% vs 77%, respectively) were statistically indistinguishable. CONCLUSIONS: Actigraphy is a valid proxy for monitoring of sleep in this population across injury severity and common comorbidity groups. However, further research with larger sample sizes to examine concordance in patients with TBI with disorder of consciousness and spasticity is recommended.
OBJECTIVE: To examine concordance of accelerometer-based actigraphy (ACG) with polysomnography (PSG) in the determination of sleep states in inpatients with traumatic brain injury (TBI), and examine the impact of injury severity and comorbid conditions (spasticity, apnea) on concordance. PARTICIPANTS: This was a convenience sample of 50 participants with primarily severe TBI. DESIGN: This was a retrospective chart review of concurrent administration of PSG with ACG in nonconsecutive rehabilitation admissions with TBI. MAIN MEASURES: Total sleep time and sleep efficiency were measured by PSG and ACG. RESULTS: Moderate to strong correlations between ACG and PSG were observed for total sleep time (r = 0.78, P < .01) and sleep efficiency (r = 0.66, P < .01). PSG and ACG estimates of total sleep time (316 minutes vs 325 minutes, respectively) and sleep efficiency (78% vs 77%, respectively) were statistically indistinguishable. CONCLUSIONS: Actigraphy is a valid proxy for monitoring of sleep in this population across injury severity and common comorbidity groups. However, further research with larger sample sizes to examine concordance in patients with TBI with disorder of consciousness and spasticity is recommended.
Authors: Catherine Duclos; Marie Dumont; Caroline Arbour; Jean Paquet; Hélène Blais; David K Menon; Louis De Beaumont; Francis Bernard; Nadia Gosselin Journal: Neurology Date: 2016-12-21 Impact factor: 9.910
Authors: Julien Lauzier Bigué; Catherine Duclos; Marie Dumont; Jean Paquet; Hélène Blais; David K Menon; Francis Bernard; Nadia Gosselin Journal: J Clin Sleep Med Date: 2020-01-13 Impact factor: 4.062
Authors: Monika Angerer; Manuel Schabus; Marion Raml; Gerald Pichler; Alexander B Kunz; Monika Scarpatetti; Eugen Trinka; Christine Blume Journal: BMC Med Date: 2020-05-12 Impact factor: 11.150